Skip to main content
https://pbs.twimg.com/media/FOYca7kXsAAL3bj.jpg
Lit review of MDA5 antibody-positive clinically amyopathic dermatomyositis w/ ILD - shows limited data from 15 studies, 388 pts, 1 RCT: ? best survival with high-dose steroids + immunosuppressive (CTX or CyA/tacrolimus). Refractory dz Rx w/PLEX, Tofa, RTX https://t.co/LIl23O6x2Y https://t.co/qvISwpr7Mw
Dr. John Cush
Mar-21-2022
×